» Articles » PMID: 17221282

Continuous Ambulatory Peritoneal Dialysis in Patients with Renal Failure Due to Multiple Myeloma

Overview
Publisher Springer
Specialty Nephrology
Date 2007 Jan 16
PMID 17221282
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Continuous ambulatory peritoneal dialysis (CAPD) is being used only in limited number of patients with renal failure due to multiple myeloma, despite having better preservation of hemoglobin, higher clearance of paraproteins, and higher chances of recovery of renal function than maintenance hemodialysis. We are reporting our short-term experience of five patients with multiple myeloma who presented with renal failure and required long term continuous ambulatory peritoneal dialysis for the treatment of uremia.

Citing Articles

Statin therapy in peritoneal dialysis patients: effects beyond lipid lowering.

Paraskevas K Int Urol Nephrol. 2007; 40(1):165-70.

PMID: 18066677 DOI: 10.1007/s11255-007-9307-6.

References
1.
. Analysis and management of renal failure in fourth MRC myelomatosis trial. MRC working party on leukaemia in adults. Br Med J (Clin Res Ed). 1984; 288(6428):1411-6. PMC: 1441033. DOI: 10.1136/bmj.288.6428.1411. View

2.
Brown J, Maxwell A, Bruce I, Murphy B, Doherty C . Renal replacement therapy in multiple myeloma and systemic amyloidosis. Ir J Med Sci. 1993; 162(6):213-7. DOI: 10.1007/BF02945197. View

3.
Cosio F, Pence T, Shapiro F, Kjellstrand C . Severe renal failure in multiple myeloma. Clin Nephrol. 1981; 15(4):206-10. View

4.
Rosansky S, Richards F . Use of peritoneal dialysis in the treatment of patients with renal failure and paraproteinemia. Am J Nephrol. 1985; 5(5):361-5. DOI: 10.1159/000166963. View

5.
Kyle R . Multiple myeloma: review of 869 cases. Mayo Clin Proc. 1975; 50(1):29-40. View